These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6889911)

  • 1. Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma.
    Brenner J; Magill GB; Sordillo PP; Cheng EW; Yagoda A
    Cancer; 1982 Nov; 50(10):2031-3. PubMed ID: 6889911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin. A phase II evaluation in previously untreated patients with soft tissue sarcomas.
    Sordillo PP; Magill GB; Brenner J; Cheng EW; Dosik M; Yagoda A
    Cancer; 1987 Mar; 59(5):884-6. PubMed ID: 3815267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Beecham J; Homesley H; Yordan E
    J Clin Oncol; 1991 Nov; 9(11):1962-6. PubMed ID: 1941054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
    Chang P; Levine MA; Wiernik PH; Walker MD
    Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of cisplatin in small cell carcinoma of the lung.
    Levenson RM; Ihde DC; Huberman MS; Cohen MH; Bunn PA; Minna JD
    Cancer Treat Rep; 1981; 65(9-10):905-7. PubMed ID: 6268297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
    Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Wagener DJ; Somers R; Santoro A; Verweij J; Woll PJ; Blackledge G; Schütte HJ; Lentz MA; van Glabbeke M
    Eur J Cancer; 1991; 27(12):1604-5. PubMed ID: 1782068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cisplatin for metastatic soft tissue sarcoma.
    Budd GT; Metch B; Balcerzak SP; Fletcher WS; Baker LH; Mortimer JE
    Cancer; 1990 Feb; 65(4):866-9. PubMed ID: 2297655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
    De Jager R; Longeval E; Klastersky J
    Cancer Treat Rep; 1980; 64(12):1341-6. PubMed ID: 6258791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma.
    Raney RB
    Cancer Treat Rep; 1987 Apr; 71(4):407-8. PubMed ID: 3829015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Orr JW; DiSaia PJ
    Cancer Treat Rep; 1986 Feb; 70(2):271-4. PubMed ID: 3948191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II evaluation of fractionated low and single high dose cisplatin in various tumors.
    Schilcher RB; Wessels M; Niederle N; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1984; 107(1):57-60. PubMed ID: 6538200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group.
    Thigpen JT; Lagasse L; Homesley H; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):431-5. PubMed ID: 6683465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
    Verweij J; Krzemieniecki K; Kok T; Poveda A; van Pottelsberghe C; van Glabbeke M; Mouridsen H
    Eur J Cancer; 1993; 29A(2):208-9. PubMed ID: 8422284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Lagasse LD; DiSaia PJ; Homesley HD
    Am J Clin Oncol; 1984 Jun; 7(3):253-6. PubMed ID: 6539565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of astrocytoma with a 5-day cisplatin infusion.
    Grunberg SM; Bertram JH; McDermed JE; Apuzzo ML
    Cancer Drug Deliv; 1987; 4(1):47-53. PubMed ID: 3607722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
    Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.